CoChat

OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 17 of the 34 sources its claims cite were checked for support.

Abstract

OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years. Participants include 605 cognitively normal adults and 493 individuals at various stages of cognitive decline ranging in age from 42 to 95 years. The OASIS-3 dataset contains over 2000 MR sessions, including multiple structural and functional sequences. PET metabolic and amyloid imaging includes over 1500 raw imaging scans and the accompanying post-processed files from the PET Unified Pipeline (PUP) are also available in OASIS-3. OASIS-3 also contains post-processed imaging data such as volumetric segmentations and PET analyses. Imaging data is accompanied by dementia and APOE status and longitudinal clinical and cognitive outcomes. OASIS-3 is available as an open access data set to the scientific community to answer questions related to healthy aging and dementia.

Overview

CoChat Summary

TL;DR

OASIS-3 is an open-access compilation of longitudinal MRI, PET, clinical, and cognitive data from 1098 participants collected over 15 years at the Washington University Knight ADRC, spanning cognitively normal aging and early-stage Alzheimer disease. The paper describes the dataset's contents, processing pipelines (FreeSurfer, PUP, Centiloid), and exploratory analyses demonstrating feasibility of volumetric and amyloid analyses.

Key findings

  • The release includes 1098 participants aged 42.5–95.6 years: 605 cognitively normal adults and 493 at various stages of cognitive decline; 850 entered with CDR 0 (605 remained normal, 245 converted), and 248 entered with CDR > 0. The APOE ε4 allele was present in 439 participants.
  • Imaging inventory: 2168 MR sessions (236 at 1.5T, 1932 at 3T) and 1608 PET sessions (999 PiB, 492 Florbetapir/AV45, 117 FDG); 1912 FreeSurfer segmentations passed QC, and PUP post-processing was included for 1356 PET sessions.
  • Exploratory analyses showed a significant baseline whole-brain volume group difference (F(2,974) = 32.36, p < 0.001), with greater annual atrophy in those entering with dementia (−2.01%/year, SD = 2.15) and converters (−1.68%/year, SD = 1.91) versus stable controls (−1.13%/year, SD = 1.49).
  • Baseline amyloid differed significantly across groups (F(2,724) = 191.39, p < 0.001), but rate of amyloid deposition did not differ (F(2,330) = 0.19, p > 0.05); baseline amyloid correlated with later conversion while baseline whole-brain volume did not.

Methods

  • Design: data descriptor compiling participants from several ongoing Knight ADRC studies (Memory and Aging Project, Adult Children Study, Healthy Aging and Senile Dementia) recruited over 15 years, with clinical/cognitive assessments standardized via the Uniform Data Set (UDS) and dementia staged by CDR.
  • Data: structural and functional MRI (T1w, T2w, FLAIR, DTI, BOLD, ASL, SWI, TOF, fieldmaps), amyloid (PiB, AV45) and metabolic (FDG) PET, APOE genotyping, and longitudinal clinical/cognitive outcomes; images converted to NIfTI/BIDS and de-identified.
  • Analysis: MRI processed with FreeSurfer for volumetric segmentation; PET processed with the PET Unified Pipeline (PUP) including partial volume correction and Centiloid standardization; exploratory group comparisons (stable controls, converters, dementia at entry) used ANOVA and t-tests on whole-brain volume and amyloid measures.

Limitations

  • Stated: a standardized visit structure was not maintained across data collection, so investigators must use "days from entry" or "age at visit" to link imaging and clinical visits, and no association between visits was imposed; there is no categorical variable indicating healthy versus Alzheimer Disease status.
  • Stated: the published OASIS datasets (Cross-sectional, Longitudinal, OASIS-3) contain overlapping participant data and should never be combined or aggregated, and links across datasets cannot be provided.
  • Evident from the text: the exploratory analyses are described by the authors as "cursory" and "exploratory descriptive analyses" rather than confirmatory tests, and imaging was acquired across multiple scanner models and field strengths over 10+ years.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1101/2019.12.13.19014902

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

13 tests recomputed · 0 with the reported and recomputed p on opposite sides of .05

Verification

Claims the paper makes

12 Valid · 0 Not valid · 8 Not checked · 80 Own results and interpretations

35 more claims

Create a free account to see all 100 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 45

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistics that don’t add up

Each reported p-value recomputed from its test statistic and degrees of freedom.

1 of 1

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Doesn’t add upt(370) = 3.02reported p = .002 · recomputed p = .003

    “t (370) = 3.02, p = .002”

  • ConsistentF(2, 974) = 32.36reported p < .001 · recomputed p < .001

    “F(2,974) = 32.36, p < .001”

  • Consistentt(749) = 7.98reported p < .001 · recomputed p < .001

    “t (749) = 7.98, p < .001”

  • Consistentt(424) = 5.77reported p < .001 · recomputed p < .001

    “t (424) = 5.77, p < .001”

  • Consistentt(771) = 1.54reported p = .125 · recomputed p = .124

    “t (771) = 1.54, p = .125”

5 of 13 · the rest aren’t loaded

8 more recomputed tests

Create a free account to see every test the Stats check recomputed.

See all tests — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 66 references

Cited by

See all 788

Metadata

Authors
LaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., Raichle, M. E., Cruchaga, C., & Marcus, D.
Affiliations
Washington University in St. Louis (US)
Corresponding author
LaMontagne, Pamela J.
Venue
medRxiv
Publisher
openRxiv
Published
2019-12-15
OpenAlex
W2995808388
Cited by
779
References
62
Citations by year
2026: 98 · 2025: 158 · 2024: 155 · 2023: 142 · 2022: 125 · 2021: 73 · 2020: 27
Type
posted content
Language
en
Open access
Licence
cc-by-nd
Locations
medRxiv (acceptedVersion, cc-by-nd)
Funders
  • Eli Lilly and Company
  • National Institutes of Health (P30 NS09857781, UL1TR000448, P50 AG00561)
  • Avid Radiopharmaceuticals
  • Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis (P01AG003991)
  • National Institute on Aging (R01AG043434, P01AG003991, P01AG026276)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB009352)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
Keywords
OASIS-3, Alzheimer's disease, normal aging, cognitive decline, longitudinal neuroimaging, structural MRI, functional MRI, positron emission tomography, amyloid imaging, glucose metabolism, 3D image segmentation, dementia, apolipoprotein E, cognitive outcomes, healthy aging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease. https://app.cochat.ai/papers/10.1101/2019.12.13.19014902
The paper
LaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., Raichle, M. E., Cruchaga, C., & Marcus, D. (2019). OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease. medRxiv. https://doi.org/10.1101/2019.12.13.19014902

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.